Radcliffe Infirmary, Woodstock Rd., OXFORD. OX2 6HEThe consumption of fish-oil has, for some time, been known to lower plasma triglyceride levels [I]. This knowledge has been beneficial in the treatment of hypcrtriglyceridaemia [2]. The mechanism, however, by which this reduction is achieved has not yet been fully elucidated but the main active ingredients are believed to be the n-3 fatty acids eicosapentaenoic acid (EPA,C20:5) and docosahexaenoic acid (DHA,C22:6). Triacyglycerol (TAG) is extremely hydrophobic and is carried in plasma as very-low-densitylipoprotein (VLDL). VLDL consists of apoproteins (including apolipoprotein B), TAG, cholesteryl ester, phospholipid and free cholesterol [3]. Apolipoprotein B is believed to provide the main structural h e w o r k for VLDL and exists as two forms. These forms are apoBlw, which is the full length protein of molecular mass 515,000 and apoBlr. ApoBla (250,000) is produced from an edited form of the apoBIw mRNA [4]. In humans, apoB4a is produced in the gut (chylomicrons) and BIm by the liver. In the rat, however, apoB4g accounts for around 60% of apoB secreted by the liver [3].It had previously been shown that EPA, when added to cells in-vitro, causes increased degradation of apoB and therefore reduced secretion [5]. However, the effects of fish-oils administered in the diet are somewhat different. We have shown that fish-oil feeding in rats leads to reduced synthesis and degradation of apoB48 [a]. The aim of the present study was to try to understand the causes of these effects, particularly the decreased degradation.. It has been postulated that cholesterol ester has an important influence on the intracellular degradation of a p B in the human hepatoma cell line HepG2 [7,8] controlling apoB entry into the secretory apparatus i.e. that cholesterol ester, in some way, protects apoB from pre-secretory degradation. We asked the question fustly, whether addition of an inhibitor of cholesterol esterification affected apoB turnover. Second, whether the inhibitor potentiated the suppressive effect of fish-oil feeding on VLDL secretion. YM17E was chosen as it is a potent inhibitor of Acyl-coAcholesterol acyltransferase (ACAT) [9].Male Wistar rats were fed for two weeks with either a fish-oil [FO] diet or a normal low-fat [LF] diet. The FO diet consisted of 20% (v/w) Maxepa mixed with the LF diet. Hepatocyte cultures were prepared as described previously [6] in supplemented Waymouth's medium. Newly-synthesised protein was pulse-labelled with "S-methionine (1OOpci /dish) for Ih in the presence or absence of YMI7E (4.4pM in DMS0,ZOpI). This was followed by chasing for up to 24h in the presence of lOmM unlabelled methionine in Waymouth's media with or without YM17E. AAer culture, the cells were separated and homogenised, and the cell media were centrifuged at 40,0001pm for 16h to separate the d<1.006 VLDL hction from the d>1.006 fraction containing smaller particles. Total apoB was then immuno-precipitated h m each fraction using a polyclonal antibody followed by SDS-PAGE elect...